Camelid-derived Tcell engagers harnessing human γδ T cells as promising antitumor immunotherapeutic agents.

MLA

Boutin, Lola, et al. “Camelid-Derived Tcell Engagers Harnessing Human Γδ T Cells as Promising Antitumor Immunotherapeutic Agents.” European Journal of Immunology, vol. 54, no. 8, Aug. 2024, p. e2350773. EBSCOhost, https://doi.org/10.1002/eji.202350773.

APA

Boutin, L., Barjon, C., Chauvet, M., Lafrance, L., Senechal, E., Bourges, D., Vigne, E., & Scotet, E. (2024). Camelid-derived Tcell engagers harnessing human γδ T cells as promising antitumor immunotherapeutic agents. European Journal of Immunology, 54(8), e2350773. https://doi.org/10.1002/eji.202350773

Chicago

Boutin, Lola, Clément Barjon, Morgane Chauvet, Laura Lafrance, Eric Senechal, Dorothée Bourges, Emmanuelle Vigne, and Emmanuel Scotet. 2024. “Camelid-Derived Tcell Engagers Harnessing Human Γδ T Cells as Promising Antitumor Immunotherapeutic Agents.” European Journal of Immunology 54 (8): e2350773. doi:10.1002/eji.202350773.